Business Segments Harvard Bioscience, Inc.
Stocks
HBIO
US4169062043
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 8.340 USD | +2.58% |
|
+4.77% | +24.70% |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Medical Products | 119M | 113M | 112M | 94.14M | 86.55M | |||||
Total Assets | 162M | 145M | 137M | 127M | 80.07M | |||||
Interest Expense | -1.54M | -2.55M | -3.59M | -3.21M | -4.92M | |||||
Income Tax Expense | 148K | 337K | 859K | 740K | -686K | |||||
CAPEX | -1.34M | -1.59M | -1.79M | -2.64M | -1.26M | |||||
EBT | -140K | -9.18M | -2.56M | -11.66M | -57.39M | |||||
Gross Profit | 67.65M | 60.82M | 66.07M | 54.77M | 49.91M | |||||
D&A | 7.62M | 7.58M | 7M | 7.16M | 5.94M | |||||
Operating Income | 2.07M | -6.93M | 1.89M | -6.21M | -48.58M | |||||
Net Income | -288K | -9.52M | -3.42M | -12.4M | -56.7M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 49.83M | 49.91M | 48.2M | 41.74M | 38.97M | |||||
Total Assets | 31.51M | 26.05M | 21.56M | 20.24M | 15.66M | |||||
Europe, Middle East and Africa | - | - | - | 28.4M | 26.71M | |||||
China | - | 16.39M | 18.49M | 13.3M | 10.97M | |||||
| - | - | - | - | 3.23M | ||||||
Asia - Other | - | - | - | 7.1M | 6.68M | |||||
| - | - | - | - | 26.71M | ||||||
Americas - Other | - | - | - | 3.6M | 3.23M | |||||
| - | - | - | - | 6.68M | ||||||
Asia | 24.82M | - | - | - | - | |||||
| - | - | - | - | 10.97M | ||||||
Europe | 35.77M | 30.69M | 32.8M | - | - | |||||
Germany | - | - | - | - | - | |||||
Total Assets | 3.5M | 2.43M | 1.7M | 1.15M | 2.31M | |||||
United Kingdom | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Rest of the World | 8.49M | 16.34M | 12.76M | - | - | |||||
Total Assets | 2.45M | 1.49M | 1.32M | 792K | 1.41M | |||||
| - | - | - | - | 38.97M |
- Stock Market
- Stocks
- HBIO Stock
- Financials Harvard Bioscience, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
